Jan 11, 2024 / 05:00PM GMT
Unidentified Participant
Thank you for joining us today. We continue the 42nd Annual JPMorgan Healthcare Conference. Pleased to join by the Emergent BioSolutions today. By Interim CEO Haywood Miller; and CFO Richard Lindahl. Though beginning with the presentation followed by Q&A session.
If you have any questions, please just raise your hand and some of them will be given mike to ask the questions, If not, assemble it to portal, I will be read out that for you. With that I will turn over to Haywood.
Haywood Miller - Emergent BioSolutions Inc - Interim Chief Executive Officer
Thank you. Hello, I'm Haywood Miller. I'm the Interim CEO of Emergent BioSolutions. I've been with the company since July and really have enjoyed my time with the management team this is a company that really is mission focused.
The management team reflects that the employees have reflected that morale has remained strong, even though I suspect if you're in this room, everyone knows the challenges we faced so that that part of the business has been very gratifying.
So
Emergent BioSolutions Inc at JPMorgan Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers